MCR Labs ‘Ask An Expert’ Virtual Event Seeks To Clear Up Mass. Cannabis Confusion

Cannabis experts will weigh in on questions submitted by members of the general public as part of a virtual panel discussion hosted by MCR Labs on October 28.

MASSACHUSETTS:  MCR Labs is organizing a virtual panel discussion for members of the public to submit cannabis-related questions to four experts with backgrounds in cannabis testing, research, medicine, and cultivation in order to help new and experienced cannabis consumers expand their knowledge of a complex and often misunderstood plant.

“Even though it’s legal here in Massachusetts, cannabis is still scary and confusing to some and complicated or overwhelming to others,” said MCR Labs President and founder Michael Kahn. “We’re trying to create more opportunities for everyone to get real answers from legitimate sources since there’s still a lot of misinformation being spread about cannabis and marijuana.”

The virtual event, titled “Ask an Expert,” will feature qualified cannabis professionals from a variety of fields and specialties. The panel discussion will include Scott Churchill, Director of Scientific Operations at MCR Labs, a cannabis testing laboratory; Dr. Marion McNabb, President of the Cannabis Center of Excellence, a research and advocacy group; Dr. Benjamin Caplan, Chief Medical Officer at the CED Clinic, a medical cannabis clinic; and Noni Goldman, Co-Founder of Four Trees Management Co., a consulting firm and tier 1 cultivation provisional licensee.

By bringing together experts with a diverse array of backgrounds, the MCR Labs’ outreach team hopes to enable a broad selection of individuals with any level of cannabis knowledge to hear answers to questions ranging from highly complex to basic and introductory.

“COVID-19 has created a significant lack of educational events geared toward cannabis at the same time that many are exploring using, growing, or even joining the industry for the first time,” said MCR Labs Event & Outreach Specialist Melissa Kenton. “So, we’re trying something new for us by hosting this online event because no matter what’s happening with the virus, education is critical to helping people explore cannabis safely.”

The event will take place on Wednesday, Oct. 28 starting at 11 a.m. Attendees can register in advance at https://tinyurl.com/MCRLabsAskExpertEvent. Those with questions for the panel can submit them via any of MCR Labs social media accounts by messaging @mcrlabs on most platforms or by emailing the outreach team directly at news@mcrlabs.com.

Casa Verde Capital Leads Investment In Cannabis Testing Lab Cannalysis

Snoop Dogg Venture Firm Helps Analytical Cannabis Laboratory Expand Its Nationwide Footprint

CALIFORNIA: Cannalysis, a cannabis testing laboratory, announced today a seed investment led by Casa Verde Capital. As the premier cannabis testing lab in the market, Cannalysis harnesses technology to provide best-in-class service to some of the largest cultivators and brands in California.

With California’s adult-use regulations coming into effect next year, government-mandated third party testing will create a huge demand for services. However, many existing labs are not prepared to deal with this type of volume due to inferior technology, creating significant bottlenecks in getting clean product to market. As such, Cannalysis is poised to fill this gap, with industry leading, guaranteed three business-day turnarounds.

Having built a custom platform from the ground up, Cannalysis streamlines the testing experience and puts all data in the client’s hands, providing real-time tracking and sample status updates. Furthermore, beautiful and intuitive reporting enables Cannalysis to deliver the story behind the test results, something that customers genuinely appreciate.

In that vein, Kurvana, one of the largest cannabis brands in California had this to say on its relationship with Cannalysis. “They push our high volumes of samples through analysis without impact to quality or turnaround time, and they are willing to work with us to prioritize the results we need most. Placing value in collaboration and transparency, Cannalysis has exceeded our expectations and raised our standards.”

“With a tech-first approach, Cannalysis has quickly established itself as one of the leading lab platforms in California. This approach has also positioned Cannalysis to quickly scale and establish JV partners around the country,” said Karan Wadhera, managing partner at Casa Verde Capital. Mr. Wadhera continued, “in fact, the first Cannalysis JV will come online in Portland early next year and we’re eager to secure new partnerships across the country to help extend the Cannalysis brand.”

Brian Lannon, CEO of Cannalysis, echoed these remarks, saying “we are at an inflection point for this industry and we are ready to expand. Having a marquee investor and strategic partner like Casa Verde, will be instrumental in helping us achieve our growth objectives.”

Digipath’s Chief Science Officer Calls For Cannabis Testing Science Standardization

NEVADA: Digipath, an independent cannabis testing laboratory and media firm, announced that its Chief Science Officer, Dr. Cindy Orser, has been invited to present on the science of cannabis at two upcoming events occurring in Nevada and California.

The first event will be at the Annual meeting of the California Association of Toxicologists entitled A House Full of Tox, being hosted by the Henderson Police Department’s and the Las Vegas Metropolitan Police Department’s forensic laboratories, and will take place Monday, November 6 and Tuesday, November 7 at the Golden Nugget hotel in Las Vegas, Nevada. From 1:30 pm to 2:30 pm on Tuesday, November 7, Dr. Orser will present on the current state of cannabis science in Nevada to enable California Toxicologists to get a snapshot of what’s to come in California with the role of a regulated cannabis industry.

The second speaking invitation came from the Genetic and Environmental Toxicology Association (GETA) of Northern Californiai. The event is entitled, The Science of Cannabis: Endocannabinoid Signaling and Pesticides in Cannabis Cultivation, and will take place Thursday, December 7 from 1:00 pm to 5:00 pm at the Elihu M. Harris State Office Building in Oakland, California.  Dr. Orser will present on the need for standardization in the cannabis industry as a prelude to the ensuing regulatory challenges ahead for the State of California under a newly regulated cannabis industry.

Dr. Cindy Orser, Chief Science Officer of Digipath, commented, “Digipath Labs is enthusiastic about participating in the scientific discussion regarding California’s burgeoning cannabis industry.”

 

AACC Annual Scientific Meeting Focuses On The Latest Research on Cannabis Use and Testing

PENNSYLVANIA: At the 68th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 31–August 4 in Philadelphia, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore the latest research on cannabis use.

As legal recreational and medical marijuana use gains traction, it is critical that law enforcement have a way to test for whether someone is driving under the influence. However, recent research has revealed that determining whether a driver is impaired by marijuana is much more complicated than testing for blood alcohol content. In a plenary session, Marilyn A. Huestis, PhD, of the National Institute on Drug Abuse, will present the latest findings on the impact of cannabis use on driving and overall health, as well as the newest developments in testing for cannabinoids in blood and saliva.

Researchers from Calgary Laboratory Services in Canada will also present a study on a new urine test to detect cannabis and its metabolites that is accurate and cost-effective.